China · Delayed Price · Currency is CNY Boji Medical Technology Statistics
Total Valuation
SHE:300404 has a market cap or net worth of CNY 5.13 billion. The enterprise value is 4.80 billion.
| Market Cap | 5.13B |
| Enterprise Value | 4.80B |
Important Dates
The next confirmed earnings date is Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
SHE:300404 has 383.08 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 383.08M |
| Shares Outstanding | 383.08M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | 34.66% |
| Owned by Institutions (%) | 1.82% |
| Float | 245.08M |
Valuation Ratios
The trailing PE ratio is 98.70.
| PE Ratio | 98.70 |
| Forward PE | n/a |
| PS Ratio | 5.34 |
| PB Ratio | 4.61 |
| P/TBV Ratio | 4.96 |
| P/FCF Ratio | 95.96 |
| P/OCF Ratio | 74.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 88.58, with an EV/FCF ratio of 89.71.
| EV / Earnings | 92.07 |
| EV / Sales | 4.99 |
| EV / EBITDA | 88.58 |
| EV / EBIT | 178.45 |
| EV / FCF | 89.71 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.92 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.80 |
| Debt / FCF | 0.81 |
| Interest Coverage | 19.06 |
Financial Efficiency
Return on equity (ROE) is 4.94% and return on invested capital (ROIC) is 3.37%.
| Return on Equity (ROE) | 4.94% |
| Return on Assets (ROA) | 1.03% |
| Return on Invested Capital (ROIC) | 3.37% |
| Return on Capital Employed (ROCE) | 2.32% |
| Weighted Average Cost of Capital (WACC) | 6.04% |
| Revenue Per Employee | 802,451 |
| Profits Per Employee | 43,510 |
| Employee Count | 1,198 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, SHE:300404 has paid 3.37 million in taxes.
| Income Tax | 3.37M |
| Effective Tax Rate | 5.97% |
Stock Price Statistics
The stock price has increased by +36.04% in the last 52 weeks. The beta is 0.33, so SHE:300404's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +36.04% |
| 50-Day Moving Average | 12.95 |
| 200-Day Moving Average | 10.73 |
| Relative Strength Index (RSI) | 50.00 |
| Average Volume (20 Days) | 43,953,266 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300404 had revenue of CNY 961.34 million and earned 52.12 million in profits. Earnings per share was 0.14.
| Revenue | 961.34M |
| Gross Profit | 238.84M |
| Operating Income | 26.89M |
| Pretax Income | 56.47M |
| Net Income | 52.12M |
| EBITDA | 52.52M |
| EBIT | 26.89M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 408.29 million in cash and 43.34 million in debt, with a net cash position of 364.95 million or 0.95 per share.
| Cash & Cash Equivalents | 408.29M |
| Total Debt | 43.34M |
| Net Cash | 364.95M |
| Net Cash Per Share | 0.95 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 2.84 |
| Working Capital | 493.49M |
Cash Flow
In the last 12 months, operating cash flow was 68.86 million and capital expenditures -15.36 million, giving a free cash flow of 53.50 million.
| Operating Cash Flow | 68.86M |
| Capital Expenditures | -15.36M |
| Depreciation & Amortization | 25.63M |
| Net Borrowing | -3.21M |
| Free Cash Flow | 53.50M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 24.84%, with operating and profit margins of 2.80% and 5.42%.
| Gross Margin | 24.84% |
| Operating Margin | 2.80% |
| Pretax Margin | 5.87% |
| Profit Margin | 5.42% |
| EBITDA Margin | 5.46% |
| EBIT Margin | 2.80% |
| FCF Margin | 5.56% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 20.71% |
| FCF Payout Ratio | 9.31% |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.16% |
| Earnings Yield | 1.02% |
| FCF Yield | 1.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2022. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2022 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:300404 has an Altman Z-Score of 5.25 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.25 |
| Piotroski F-Score | 7 |